top of page

Publications

Peer-Reviewed Publications
Peer-Reviewed
  • Development of Novel DPAGT1 Inhibitors based on Tunicamycin V and its Homologous Structures. Mitachi, K.; Kurosu, M. Journal of Synthetic Organic Chemistry, Japan. 2023, 81, 220-234. DOI: doi.org/10.5059/yukigoseikyokaishi.81.220

​

  • Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor. Mitachi, K.; Mingle, D.; Effah, W.; Sánchez-Ruiz, A.; Hevener, K.E.; Narayanan, R.; Clemons, W.M.; Sarabia, F.; Kurosu, M. Angew. Chem. Int. Ed. 2022. DOI: doi.org/10.1002/anie.202203225

​

  • DPAGT1 Inhibitors of capuramycin analogues and their antimigratory activities of solid tumors. Mitachi, K.; Kansal, R.; Hevener, K.; Gillman, C.; Yun, H-G.; Hussain, M.; Miranda-Carboni, G.; Glazer, E.; Clemons, W. M.; Kurosu, M. J. Med. Chem. 2020, 63, 10855-10878. DOI: 10.1021/acs.jmedchem.0c00545

​

  • Substrate Tolerance of Bacterial Glycosyltransferase MurG: Novel Fluorescence-based Assays. Mitachi, K.; Yun, H-G.; Gillman, C.; Skorupinska-Tudek, K.; Swiezewska, E.; Clemons, W. M.; Kurosu, M. ACS Inf. Dis. 2020, 6, 1501-1516. DOI: 10.1021/acsinfecdis.9b00242

​

  • Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis. Lelovic, N.; Mitachi, K.; Yang, J.; Lemieux, M. R.; Ji, Y.; Kurosu, M. J. Antibiotics 2020, 73, 780-789. DOI: doi.org/10.1038/s41429-020-0320-7

​

  • A practical synthesis of a novel DPAGT1 inhibitor, aminouridyl phenoxypiperidinbenzyl butanamide (APPB) for in vivo studies. Mitachi, M.; Kurosu, S. M.; Gillman, C. D.; Yun, H-G.; Clemons, W. M.; Kurosu, M. MethodsX 2019, 6, 2305-2321. doi.org/10.1016/j.mex.2019.09.031

​

  • Structure-based drug discovery N-glycan biosynthesis, dolichyl-phosphate N-acetylglucosaminephosphotransferase. Kurosu, M. Future Med. Chem. 2019, 11, 927-933. doi.org/10.4155/fmc-2018-0405

​

  • Semisynthesis of an Anticancer DPAGT1 Inhibitor from a Muraymycin Biosynthetic Intermediate. Mitachi, K.; Kurosu, M. S.; Eslamimehr, S.; Lemieux, M. R.; Ishizaki, Y.; Clemons C. M. Jr., Kurosu, M. Org. Lett. 2019,214, 876-879. doi.org10.1021/acs.orglett.8b03716

​

  • Novel FR-900493 Analogs that Inhibit Germination of Clostridium difficile Spores. Mitachi, K.;  Yun, H-G.; Kurosu, S. M.; Eslamimehr, S.; Lemieux, M. R.; Klaić, L.; Clemons C. M. Jr., Kurosu, M.ACS Omega. 2018

​

  • A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of MDR Acinetobacter baumannii. Siricilla,S.; Mitachi,K.; Yang, J.; Eslamimehr, S.; Lemieux, M. R.; Meibohm, B.; Ji, Y.; Kurosu, M. J. Med. Chem. 2017, 60, 2869-2878.

​

  • Stereocontrolled Total Synthesis of Muraymycin D1 Having a Dual Mode of Action against Mycobacterium tuberculosis. Mitachi, K.; Aleiwi, B. A.; Schneider, C. M.; Siricilla, S.; Kurosu, M. J. Am. Chem. Soc. 2016, 138, 12975-12980.

​

  • Fluorescence-based assay for polyprenyl phosphate-GlcNAc-1-phosphate transferase (WecA) and identification of novel antimycobacterial WecA inhibitors. Mitachi, K.; Siricilla, S.; Yang, D.; Kong, Y.; Skorupinska-Tudek, K.; Swiezewska, E.; Franzblau, S. G.; Kurosu, M. Analytical Biochemistry 2016, 512, 78-90.

​

  • Structure determination of lipopeptides from Mycobacterium avium subspecies paratuberculosis and identification of antigenic lipopeptide probes. Mitachia, K.; Sharma Gautama L.H.; Rice, J. H.; Eda K.; Wadhwa A.; Momotani, E.; Hlopak, J. H.; Eda, S.; Kurosu, M. Analytical Biochemistry 2016, 505, 29-35.

​

  • Discovery of a Capuramycin analog that Kills Non-replicating Mycobacterium tuberculosis and Its Synergistic Effects with Translocase I Inhibitors. Siricilla, S.; Mitachi, K.; Wan, B.; Franzblau, S. G.; Kurosu, M. J. Antibiot. 2014, 68, 271-278.

​

  • One-Pot Protection-Glycosylation Reactions for Synthesis of Lipid II Analogues. Katsuhiko, M.; Priya, M.; Shajila, S.; Kurosu, M. Chem. A Europ. J. 2014, 20, 4554-4558.

​

  • Biosynthesis of A Water-Soluble Lipid I Analogue and A Convenient Assay for Translocase I. Siricilla, S.; Mitachi, K.; Skorupinska-Tudek, K.; Swiezewska, E.; Kurosu, M. Analytical Biochem. 2014, 46, 36-45.

​

  • Improved Synthesis of Capuramycin and Its Analogs. Wnag, Y.; Siricilla, S.; Aleiwi, B. A.; Kurosu, M. Eur. Chem. A Europ. J. 2013, 19, 13847-13858.

​

  • Advances in MRSA drug discovery: where are we and where do we need to be? Kurosu, M.; Mitachi, K.; Siricilla, S. Expert Opni. Rev. 2013, 8, 1095-1116.

​

  • Selective Esterifications of Primary Alcohols in a Water-Containing Solvent. Wang, Y.; Aleiwi, B. A.; Wang, Q.; Kurosu, M. Org. Lett. 2012, 14, 4910-4913.

​

  • A New Oxyma Derivative for Non-racemizable Amide-forming Reactions in Water. Wang, Q.; Wang, Y.; Kurosu, M. Org. Lett. 2012, 14, 3372-3375.

​

  • Vitamin K2 in Electron Transport System: Are Enzymes Involved in Vitamin K2 Biosynthesis Promising Drug Targets? Kurosu, M.; Begari, E. Molecules, 2010, 15, 1531-1553.

​

  • Bacterial Protein Kinase Inhibitors. Kurosu, M.; Begari, E. Drug Development Research 2010, 71, 168-187.

​

  • A Concise Synthesis of Capuramycin. Kurosu, M.; Li, K.; Crick, D. C. Org. Lett. 2009,11, 2393-2396.

​

  • New Chiral Derivatizing Agents: Convenient Determination of Absolute Determination of Free Amino Acids by 1H-NMR. Kurosu, M.; Li, K. Org. Lett. 2009, 11, 911-914.

​

  • MenA Is a Promising Drug Target for Developing Novel lead Molecules to Combat Mycobacterium tuberculosis. Kurosu, M.; Crick, D. C. Medicinal Chemistry 2009, 5, 197-207.

​

  • Menaquinone Synthesis Is Critical for Maintaining Mycobacterial Viability During Exponential Growth and Recovery from Non-replicating Persistence. Dhiman, R. K.; Mahapatra, S.; Slayden, R. A.; Boyne, M. E.; Lenaerts, A.; Hinshaw, J. C.; Angala, S. K.; Chatterjee, D.; Biswas, K.; Narayanasamy, P.; Kurosu, M.; Crick, D. C. Molecular Microbiology 2009, 72, 85-97.

​

  • Discovery of 1,4-Dihydroxy-2-naphthoate Prenyltransferase Inhibitors: New Drug Leads for Multidrug-Resistant Gram-Positive Pathogens. Kurosu, M.; Narayanasamy, P.; Biswas, K.; Dhiman, R.; Crick, D. C. J. Med. Chem. 2007, 50, 3973-3975.

​

  • Polymer-Supported (2,6-Dichloro-4-alkoxyphenyl) (2,4-dichlorophenyl) methanol: A New Linker for Solid-Phase Organic Synthesis. Kurosu, M.; Biswas, K.; Crick, D. C. Org. Lett. 2007, 9, 1141-1144.

Natural Product Chemistry (Highlighted)
  • Stereocontrolled Total Synthesis of Muraymycin D1 Having a Dual Mode of Action against Mycobacterium tuberculosis. Mitachi, K.; Aleiwi, B. A.; Schneider, C. M.; Siricilla, S.; Kurosu, M. J. Am. Chem. Soc. 2016, 138, 12975-12980.

​

  • Improved Synthesis of Capuramycin and Its Analogs. Wnag, Y.; Siricilla, S.; Aleiwi, B. A.; Kurosu, M. Eur. Chem. A Europ. J. 2013, 19, 13847-13858.

​

  • A New Oxyma Derivative for Non-racemizable Amide-forming Reactions in Water. Wang, Q.; Wang, Y.; Kurosu, M. Org. Lett. 2012, 14, 3372-3375.

​

  • Selective Esterifications of Primary Alcohols in a Water-Containing Solvent. Wang, Y.; Aleiwi, B. A.; Wang, Q.; Kurosu, M. Org. Lett. 2012, 14, 4910-4913.

​

  • A Concise Synthesis of Capuramycin. Kurosu, M.; Li, K.; Crick, D. C. Org. Lett. 2009,11, 2393-2396.

​

  • Ganglioside GM3 Derivatives with Truncated Ceramide Moiety: Facial Synthesis and Inhibitory Activity Against KB Cell Growth. Kurosu, M.; Kitagawa, I. J. Carbohydrate.Chem. 2006, 25, 427.

​

  • Fe/Cr-and Co/Cr Mediated catalytic Asymmetric 2-Haloallylations of Aldehydes. Kurosu, M.; Lin, M-H.; Kishi, Y, J. Am.Chem. Soc. 2004, 126, 12248-12249.

​

  • Total Synthesis of (±)-Batrachotoxinin A. Kurosu, M.; Marcin, L. R.; Grinsteiner, T. J.; Kishi. Y. J. Am. Chem. Soc. 1998, 120, 6627-6628.

​

  • A Novel Example for Optical Resolution of Racemic Ketones Originating from Batrachotoxin Synthesis. Kurosu, M.; Kishi, Y. J. Org. Chem. 1998, 63, 6100-6101.

Highlighted
Books
Books
  • Medicinal Chemistry of Chemotherapeutic Agents, Editors Archarya, P.; Kurosu, M. ELSEVIER UK (2023)

​

  • Cell Wall Biosynthesis and Latency during Tuberculosis Infections, Kurosu, M.  in Tuberculosis Host-Pathogen Interactions, Springer 2019 Jeffrey D. Cirillo

​

  • Advances in Tuberculosis Medicinal Chemistry, Editors Kurosu, M. Future Science Ltd, Unitec House, UK (2016)

​

  • Vitamin K2 Biosynthesis: Drug Targets for New Antibacterials. InTech. (2016). "Vitamin K2", ISBN 978-953-51-4691-9.

​

  • Biologically Active Molecules from Soybeans in Soybean and Health (2011), 1-24, INTECH, ISBN 978-953-307-535-8

​

  • Electrophile cleavable linker unit In Linker Strategies in Solid-Phase Organic Synthesis (2009), 27-76    John Wiley and Sons, Ltd.

10_edited.jpg
Available Now!
New Book
Also Available Here:
Amazon Link
Walmart Link
Target Link
Barnes & Noble Link
Patents
  • Glycosyltransferase inhibitors for treatment of solid tumors. Kurosu, M.; Clemons, Clemons, W. M. International Patent Application No. PCT/US2019/013152, filed January 12, 2019.

​

  • Pleuromutilin derivatives and uses thereof: U.S Provisional Application February, 2017. Kurosu, M.

​

  • Compounds for amide-forming reactions, Patent number: WO 2013180815, Issue date: March 15, 2013. Kurosu, M

​

  • Composition for the Treatment of Tuberculosis and Methods of Using Same, WO 2013-US24290,  Issue date: Feb 1, 2013. Kurosu, M

​

  • Improved Synthesis of Capuramycin and its Analogues: U.S Provisional Application No.: 61/869,390 Filed September, 2013. Kurosu, M.

​

  • (2,2-Dimethyl-1,3-dioxolane-4yl)methyl 2-cyano-2-(hydroxyimino)acetate and Method of Use, Filed May 10, 2012. Kurosu, M.

​

  • Compositions and Methods of Use of Electron Transport System Inhibitors Serial Number: PCT / US, 2007 / 63122. Kurosu, M.

​

  • Acid and Base Stable Diphenylmethanol Derivatives and Methods of Use. U.S. Pat. Appl. Publ. 2008, US 2008200719  A1 20080821. Kurosu, M.

Patents
bottom of page